Quantum Genomics (Alternext – FR0011648971 – ALQGC), ), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, will be participating at the 10th edition of the European Smallcap Event, a conference dedicated to meetings between European listed companies and institutional investors, to be held in Paris on April 27 & 28, 2015.
[button link=”http://www.quantum-genomics.com/www/wp-content/uploads/2015/04/QGC_PR_Small-Cap-Event-04-2015_20150416_UK.pdf” target=”_blank” title=”Download Press Release” size=”small” color=”red”]
